Unknown

Dataset Information

0

Comparative Proteomics of Activated THP-1 Cells Infected with Mycobacterium tuberculosis Identifies Putative Clearance Biomarkers for Tuberculosis Treatment.


ABSTRACT: Biomarkers for determining clearance of Mycobacterium tuberculosis (Mtb) infection during anti-tuberculosis therapy or following exposure could facilitate enhanced monitoring and treatment. We screened for biomarkers indicating clearance of Mtb infection in vitro. A comparative proteomic analysis was performed using GeLC MSI/MS. Intracellular and secreted proteomes from activated THP-1 cells infected with the Mtb H37Rv strain (MOI = 1) and treated with isoniazid and rifampicin for 1 day (infection stage) and 5 days (clearance stage) were analyzed. Host proteins associated with early infection (n = 82), clearance (n = 121), sustained in both conditions (n = 34) and suppressed by infection (n = 46) were elucidated. Of the potential clearance markers, SSFA2 and CAECAM18 showed the highest and lowest protein intensities, respectively. A western blot of CAECAM18 validated the LC MS/MS result. For three clearance markers (SSFA2, PARP14 and PSME4), in vivo clinical validation was concordantly reported in previous patient cohorts. A network analysis revealed that clearance markers were enriched amongst four protein interaction networks centered on: (i) CD44/CCND1, (ii) IFN-?1/NF-?B, (iii) TP53/TGF-? and (iv) IFN-?/CCL2. After infection, proteins associated with proliferation, and recruitment of immune cells appeared to be enriched possibly reflecting recruitment of defense mechanisms. Counteracting proteins (CASP3 vs. Akt and NF-?B vs. TP53) associated with apoptosis regulation and its networks were enriched among the early and sustained infection biomarkers, indicating host-pathogen competition. The BRCA1/2 network was suppressed during infection, suggesting that cell proliferation suppression is a feature of Mtb survival. Our study provides insights into the mechanisms of host-Mtb interaction by comparing the stages of infection clearance. The identified clearance biomarkers may be useful in monitoring tuberculosis treatment.

SUBMITTER: Kaewseekhao B 

PROVIDER: S-EPMC4516286 | biostudies-literature | 2015

REPOSITORIES: biostudies-literature

altmetric image

Publications

Comparative Proteomics of Activated THP-1 Cells Infected with Mycobacterium tuberculosis Identifies Putative Clearance Biomarkers for Tuberculosis Treatment.

Kaewseekhao Benjawan B   Naranbhai Vivek V   Roytrakul Sittiruk S   Namwat Wises W   Paemanee Atchara A   Lulitanond Viraphong V   Chaiprasert Angkana A   Faksri Kiatichai K  

PloS one 20150727 7


Biomarkers for determining clearance of Mycobacterium tuberculosis (Mtb) infection during anti-tuberculosis therapy or following exposure could facilitate enhanced monitoring and treatment. We screened for biomarkers indicating clearance of Mtb infection in vitro. A comparative proteomic analysis was performed using GeLC MSI/MS. Intracellular and secreted proteomes from activated THP-1 cells infected with the Mtb H37Rv strain (MOI = 1) and treated with isoniazid and rifampicin for 1 day (infecti  ...[more]

Similar Datasets

| S-EPMC8477185 | biostudies-literature
| S-EPMC8581329 | biostudies-literature
| S-EPMC3305424 | biostudies-literature
2014-12-31 | GSE51029 | GEO
| S-EPMC7052228 | biostudies-literature
2021-06-15 | PXD021166 | Pride
| S-EPMC6713430 | biostudies-literature
| S-EPMC4345262 | biostudies-literature
2014-07-01 | GSE57028 | GEO
2024-10-24 | GSE246736 | GEO